Enzymes downstream in cholesterol biosynthesis could provide new ways to stimulate remyelination that avoid the baggage of previously identified multiple sclerosis targets, according to a group at Case Western. The university is spinning out Convelo Therapeutics Inc. to translate the idea.
Read MoreWith research from Case Western Reserve University, a Cleveland-based startup aims to develop a new class of medicines that help regenerate the insulating myelin sheath around nerve cells, which is degraded in neurological disorders such as multiple sclerosis.
Read MoreConvelo Therapeutics launched publicly on Wednesday, July 25, after working in stealth mode with a mission to discover and develop a new class of medicines for neurological disease characterized by the loss of the protective Myelin coating around nerve cells, according to a news release.
Read More